Dr K. Raghavan,
Chief Consultant, Pediatric Neurology, JAICARE, Madurai, India. .

He presented the outcome of their clinical study and explained, how a safe and disease modifying approach with neu REIX beta glucans could help delay the progress of DMD until a definitely and affordable solution to correct the gene defect reaches everyone. He added that the finding of plasma dystrophin increase has been a breakthrough in their study which when confirmed by additional evaluation may even improve the outcome of the study and that a six months study in DMD along with a two months study in LGMD is underway beside a pre-clinical study jointly with Japanese collaborators. Dr. Nguyen Thanh Liem, Professor, College of Heath Sciences, a pioneer and innovator in pediatric endoscopic surgery and stem cell transplantation from Vin University, Vietnam lauded the outcome and was open for a discussion to support such studies in Vietnam.

Dr. Naoki Yamamoto, ( Moderator )
Genome Medical Sciences Project,
National Center for Global Health and Medicine, Konodai, Ichikawa, Chiba, Japan.

Dr. Naoki Yamamoto is a distinguished scientist renowned for his groundbreaking contributions to various fields of study, with a primary focus on virology, molecular biology, immunology, and cell biology. His extensive research has left an indelible mark on the scientific community, and he is best known for his pioneering work in several key areas.
With a background in molecular biology and immunology, Dr. Yamamoto has made significant strides in the study of viruses and their interactions with the human immune system. His research spans a wide range of topics, including viral replication, interferon, dengue virus, and viral immunoprecipitation.
Throughout his career, Dr. Yamamoto's work has garnered recognition and numerous citations, with some of his most cited papers focusing on topics such as autophagy protein Atg16L1 and its impact on IL-1beta production, as well as the orchestration of leukocyte recruitment during acute inflammation by IL-6 and its soluble receptor.
In his most recent research endeavors, Dr. Yamamoto's work has delved into areas such as gene regulation, enzyme function, and DNA interactions. His multidisciplinary approach has allowed him to explore various facets of virology, virus-host interactions, and the molecular mechanisms underlying diseases.

Prof. John Solomon, ( Panelists )
Pediatric Oncologist. Emeritus Professor, The Tamil Nadu Dr. M.G.R. Medical University, Chennai, India.

Prof. Dr. P. John Solomon is a distinguished medical professional with an illustrious career dedicated to the fields of Pediatrics, Hematology, and Oncology. Dr. Solomon's academic journey is marked by an impressive array of degrees and distinctions, including an M.B.B.S., D.C.H., M.D. in Pediatrics, and an M.Med.Sc. in Haematology from the United Kingdom. His affiliation with the Queen's University and Manchester University in the UK, as well as Tel Aviv University in Israel, attests to his commitment to excellence and international collaboration in the field of pediatric oncology. One of Dr. Solomon's most notable honors is his designation as an Emeritus Professor by The Tamil Nadu Dr. M.G.R. Medical University in 2011, recognizing his outstanding contributions to the medical community. His prolific career has been punctuated by numerous awards, including the prestigious Dr. K.A. Krishnamoorthy Award of the Indian Academy of Pediatrics and the Dr. V. Balagopal Raju Award for outstanding research in pediatric medicine. Dr. Solomon's international recognition came with the International Cancer Technology Transfer Award from the Union for International Cancer Control (UICC) in 1998. Dr. Solomon's commitment to community health is exemplified by his groundbreaking work in tribal areas of Tamil Nadu, where he effectively reduced the Infant Mortality Rate from 375 to 70 through innovative programs promoting oral rehydration therapy and health education. He has been instrumental in pioneering the field of Pediatric Hematology and Oncology in Tamil Nadu, establishing the first department of its kind in the Tamil Nadu State Government at Stanley Medical College. Additionally, his initiative to create a Children's Cancer Fund in the state government has provided vital support to hundreds of underprivileged children battling cancer. Furthermore, Dr. Solomon's contributions to the scientific community extend to his publication of books on childhood cancer in both Tamil and English. He was the first to identify and report a novel splice site mutation in Fanconi's Anemia, a significant discovery published in the Italian Journal of Pediatrics. Dr. Solomon continues to push boundaries, currently conducting research on the immunological changes following COVID-19 vaccination.

Dr. Stephen Abraham Sureshkumar, ( Panelists )
Pediatric Neurologist. Former Professor of Pediatric Neurology, Government Stanley Medical College, Madras Medical College & Institute of Child Health, Chennai, India.

Dr. Stephen Abraham Sureshkumar is a highly accomplished medical professional with a remarkable career in the fields of pediatric neurology and neurology. He holds several prestigious qualifications, including an MD in Pediatrics, a DCH (Diploma in Child Health), and a DM in Neurology, showcasing his dedication to medical excellence.
Throughout his illustrious career, Dr. Sureshkumar has held prominent academic positions in esteemed medical institutions. He served as a Professor of Pediatric Neurology at the prestigious Government Stanley Medical College and Madras Medical College & Institute of Child Health and Research in Chennai, Tamil Nadu. His contributions in the field of pediatric neurology have been invaluable, benefiting countless young patients and their families.
In addition to his expertise in pediatric neurology, Dr. Sureshkumar's knowledge and leadership extended to the realm of adult neurology. He also served as a Professor of Neurology and as the Head of the Department of Neurology at Sri Balaji Medical College and Hospitals in Chrompet, Chennai, further demonstrating his versatility and dedication to advancing the field of neurology.